Cas:14564-35-3 dichlorodicarbonylbis(triphenylphosphine)ruthenium (ii) manufacturer & supplier

Chemical Name:dichlorodicarbonylbis(triphenylphosphine)ruthenium (ii)

CAS.NO:14564-35-3

Synonyms:EINECS 238-605-9;MFCD00009594;Dichlorodicarbonylbis(triphenylphosphine)ruthenium(II);Bis(triphenylphosphine)ruthenium(II) dicarbonyl chloride

Molecular Formula:C₃₈H₃₀Cl₂O₂P₂Ru

Molecular Weight:752.56700

HS Code:

Physical and Chemical Properties:

Melting point:230-235ºC

Boiling point:360ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:27.18000

Exact Mass:752.01400

LogP:7.85260

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like EINECS 238-605-9 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bis(triphenylphosphine)ruthenium(II) dicarbonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(triphenylphosphine)ruthenium(II) dicarbonyl chloride Use and application,EINECS 238-605-9 technical grade,usp/ep/jp grade.

Related News: In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. dichlorodicarbonylbis(triphenylphosphine)ruthenium (ii) manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. dichlorodicarbonylbis(triphenylphosphine)ruthenium (ii) supplier The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. dichlorodicarbonylbis(triphenylphosphine)ruthenium (ii) vendor The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. dichlorodicarbonylbis(triphenylphosphine)ruthenium (ii) factory The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment.